Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Caribou Biosciences Inc., 3 years.
Caribou Biosciences Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 3, 2025 | Vaxcyte Inc. | Shares withheld for tax | −3,809 | $72.10 | $274,629 |
| Feb 28, 2025 | Vaxcyte Inc. | Shares withheld for tax | −1,270 | $73.02 | $92,735 |
| Feb 27, 2025 | Vaxcyte Inc. | Grant or award | +22,761 | — | — |
| Feb 18, 2025 | Vaxcyte Inc. | Option exercise | +8,000 | $5.35 | $42,800 |
| Feb 18, 2025 | Vaxcyte Inc. | Open-market sale | −6,182 | $83.64 | $517,062 |
| Feb 18, 2025 | Vaxcyte Inc. | Open-market sale | −1,818 | $84.58 | $153,766 |
| Jan 21, 2025 | Vaxcyte Inc. | Option exercise | +8,000 | $5.35 | $42,800 |
| Jan 21, 2025 | Vaxcyte Inc. | Open-market sale | −5,318 | $86.08 | $457,773 |
| Jan 21, 2025 | Vaxcyte Inc. | Open-market sale | −1,999 | $87.25 | $174,413 |
| Jan 21, 2025 | Vaxcyte Inc. | Open-market sale | −683 | $87.70 | $59,899 |
| Dec 18, 2024 | Vaxcyte Inc. | Option exercise | +8,000 | $5.35 | $42,800 |
| Dec 18, 2024 | Vaxcyte Inc. | Open-market sale | −1,190 | $87.26 | $103,839 |
| Dec 18, 2024 | Vaxcyte Inc. | Open-market sale | −3,373 | $88.70 | $299,185 |
| Dec 18, 2024 | Vaxcyte Inc. | Open-market sale | −3,157 | $89.31 | $281,952 |
| Dec 18, 2024 | Vaxcyte Inc. | Open-market sale | −280 | $90.24 | $25,267 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.